Fig 1.
Flow diagram of selection process of the included studies.
Table 1.
Main characteristics of included studies.
Fig 2.
Forest plots depicting the odds ratio of clinical success rate of patients receiving extended or continuous infusion vs intermittent of meropenem.
Fig 3.
Forest plot depicting the risk ratio of mortality of patients receiving extended or continuous infusion vs intermittent of meropenem.
Fig 4.
Forest plot depicting the odds ratio of microbial eradication of patients receiving extended or continuous infusion vs intermittent of meropenem.